https://www.ncbi.nlm.nih.gov/books/NBK554776/
Chan, J. F.-W., Kok, K. H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., and Yuen, K. Y. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections, 9, 221-236. doi: 10.1080/22221751.2020.1719902
Ciechomska, I., Legat, M., Golab, J., Wesolowska, A., Kurzaj, Z., Mackiewicz, A., and Kaminska, B. (2005). Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. International Journal Of Cancer, 117, 59-67. doi:10.1002/ijc.21153
Contini, A. (2020). Virtual screening of an FDA approved drugs database on two COVID-19 coronavirus proteins. ChemRxiv. Preprint, doi:10.26434/chemrxiv.11847381.v1 Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., and Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research, 176, 104742. doi:10.1016/j.antiviral.2020.104742
Dastan, F., Tabarsi, P., Marjani, M., Moniri, A., Hashemian, S. M., Tavakoli-Ardakani, M., and Saffaei, A. (2020). Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces. Iranian Journal Of Pharmaceutical Research, 1-2. doi: